{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:50Z","timestamp":1786119170010,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/jcp.0b013e31815abefb","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T20:27:58Z","timestamp":1236198478000},"page":"614-619","source":"Crossref","is-referenced-by-count":45,"title":["Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness"],"prefix":"10.1097","volume":"27","author":[{"given":"Boadie W.","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Crits-Christoph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hirschowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Brent","family":"Solvason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Rickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Garlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Gallop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip T.","family":"Ninan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4088\/JCP.v60n0403","article-title":"Residual symptoms in patients who respond acutely to fluoxetine.","volume":"60","author":"Nierenberg","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.","volume":"58","author":"Anderson","year":"2000","journal-title":"J Affect Disord"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice.","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0278-5846(02)00226-9","article-title":"Residual symptoms in depression: an emerging therapeutic target.","volume":"26","author":"Fava","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"suppl 2","key":"R6-10-20210128","first-page":"20","article-title":"Clinical issues in long-term treatment with antidepressants.","volume":"61","author":"Zajecka","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1345\/aph.1A254","article-title":"Discontinuing or switching selective serotonin-reuptake inhibitors.","volume":"36","author":"Bull","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4088\/JCP.v66n0201","article-title":"Is there a delay in the antidepressant effect? A meta-analysis.","volume":"66","author":"Posternak","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.npp.1300341","article-title":"Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.","volume":"29","author":"Katz","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4088\/JCP.v61n1002","article-title":"How fast are antidepressants?","volume":"61","author":"Gelenberg","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.jcp.0000104910.75206.b9","article-title":"A prospective trial of modafinil as an adjunctive treatment of major depression.","volume":"24","author":"DeBattista","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4088\/JCP.v61n0510","article-title":"Modafinil augmentation of antidepressant treatment in depression.","volume":"61","author":"Menza","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4088\/JCP.v66n0112","article-title":"A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.","volume":"66","author":"Fava","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","article-title":"Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.","volume":"64","author":"DeBattista","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.v65n0318","article-title":"Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.","volume":"65","author":"Ninan","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"suppl 20","key":"R16-10-20210128","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The Fatigue Severity Scale: application to patients with multiple sclerosis and systematic lupus erythematosus.","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.","volume":"12","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"R22-10-20210128","first-page":"17","article-title":"Clinical significance of reversed vegetative subtypes of recurrent major depression.","volume":"27","author":"Thase","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00005053-198708000-00005","article-title":"Taking the measure of anxiety and depression: validity of the reconstructed Hamilton scales.","volume":"175","author":"Riskind","year":"1987","journal-title":"J Nerv Ment Dis"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","article-title":"The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.","volume":"85","author":"Mendoza","year":"1999","journal-title":"Cancer"},{"key":"R25-10-20210128","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-item short form health survey (SF-36),2: psychometric and clinical test of validity in measuring physical and mental health constructs.","volume":"31","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.","volume":"164","author":"Pack","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy.","volume":"54","year":"2000","journal-title":"Neurology"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","article-title":"Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors.","volume":"60","author":"Papakostas","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","article-title":"Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.","volume":"59","author":"Fava","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.163.1.41","article-title":"Suicide risk during antidepressant treatment.","volume":"163","author":"Simon","year":"2006","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200712000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:54Z","timestamp":1786037994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200712000-00010"}},"subtitle":["A Double-Blind, Placebo-Controlled Study"],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31815abefb","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}